Sponsor:
North Carolina State University
Code:
NCT05249595
Conditions
Incomplete Spinal Cord Injury
Transverse Myelitis
Eligibility Criteria
Sex: All
Age: 18 - 64
Healthy Volunteers: Accepted
Interventions
Surface electromypgraphy-based interface to predict human ankle joint motion intent and use in ankle assistive devices
Ultrasound imaging-based interface to predict human ankle joint motion intent and use in ankle assistive devices
Surface electromypgraphy and ultrasound imaging-based interface to predict human ankle joint motion intent and use in ankle assistive devices
Brief summary:
Conditions
Incomplete Spinal Cord Injury
Transverse Myelitis
Study ID
NCT05249595
Start date
Feb 10, 2020
Status verified date
Feb, 2022
Completion date
Dec 31, 2023
Anticipated
Primary completion date
Dec 31, 2023
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 64
Healthy Volunteers: Accepted
Enrollment
25 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Other
Arms
experimental: Group A - Particiapnts without neurological disorders
experimental: Group S - Participants with iSCI or transverse myelitis
Interventions
Surface electromypgraphy-based interface to predict human ankle joint motion intent and use in ankle assistive devices
Ultrasound imaging-based interface to predict human ankle joint motion intent and use in ankle assistive devices
Surface electromypgraphy and ultrasound imaging-based interface to predict human ankle joint motion intent and use in ankle assistive devices
Primary outcome measure
Central contacts
Locations
1807 N. Fordham Blvd. UNC Center for Rehabilitation Care of Chapel Hill
Recruiting
Chapel Hill, North Carolina, United States, 27514
Contacts
4212C Engineering Building III 1840 Entrepreneur Dr.
Recruiting
Raleigh, North Carolina, United States, 27695
Contacts
Sponsor
North Carolina State University
Last update posted
Feb 21, 2022
Last verified
Feb, 2022
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by North Carolina State University on 2022-02-21.